PMID- 23657958 OWN - NLM STAT- MEDLINE DCOM- 20131028 LR - 20191210 IS - 1097-0231 (Electronic) IS - 0951-4198 (Linking) VI - 25 IP - 18 DP - 2011 Sep 30 TI - A metabonomic analysis of urine from rats treated with rhizoma alismatis using ultra-performance liquid chromatography/mass spectrometry. PG - 2633-40 LID - 10.1002/rcm.5163 [doi] AB - A metabonomic approach based on ultra-performance liquid chromatography coupled to mass spectrometry (UPLC/MS) was used to study the nephrotoxicity of rhizoma alismatis (RA) in rats. Potential biomarkers of RA toxicity were identified and the toxicological mechanism is discussed. Urine samples were collected from control and treated rats at various stages and analyzed by UPLC/MS in positive ionization mode. Histopathological analysis was used to evaluate renal function. The differences in the metabolic profiles of the control and treated rats were clearly distinguishable with principal components analysis (PCA) of the chromatographic data, and significant changes in 13 metabolite biomarkers were detected in the urine. This metabonomic method combined with PCA could discriminate the treated rats from the control rats on days 60, 120, and 180 after treatment, before serious organic renal damage was apparent on day 180 with histopathology. This research indicates that UPLC/MS-based metabonomic analysis of urine samples can be used to predict the chronic nephrotoxicity induced by rhizoma alismatis. CI - Copyright (c) 2011 John Wiley & Sons, Ltd. FAU - Yu, Yue AU - Yu Y AD - Department of Pharmaceutical Analysis, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, 110016, PR China. FAU - Ma, Chao AU - Ma C FAU - Bi, Kaishun AU - Bi K FAU - Yang, Guoguang AU - Yang G FAU - Xie, Pu AU - Xie P FAU - Wang, Jie AU - Wang J FAU - Chen, Xiao-Hui AU - Chen XH LA - eng PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Rapid Commun Mass Spectrom JT - Rapid communications in mass spectrometry : RCM JID - 8802365 RN - 0 (Drugs, Chinese Herbal) SB - IM MH - Alisma/*chemistry MH - Animals MH - Chromatography, High Pressure Liquid/*methods MH - Disease Models, Animal MH - Drugs, Chinese Herbal/*analysis/metabolism/toxicity MH - Humans MH - Kidney/drug effects/metabolism MH - Kidney Diseases/*chemically induced/metabolism/urine MH - Male MH - Mass Spectrometry/*methods MH - Metabolomics/*methods MH - Rats MH - Rats, Wistar MH - Rhizome/adverse effects/*chemistry MH - Urine/*chemistry EDAT- 2011/09/30 00:00 MHDA- 2013/10/29 06:00 CRDT- 2013/05/10 06:00 PHST- 2011/03/02 00:00 [received] PHST- 2011/06/21 00:00 [revised] PHST- 2011/06/27 00:00 [accepted] PHST- 2013/05/10 06:00 [entrez] PHST- 2011/09/30 00:00 [pubmed] PHST- 2013/10/29 06:00 [medline] AID - 10.1002/rcm.5163 [doi] PST - ppublish SO - Rapid Commun Mass Spectrom. 2011 Sep 30;25(18):2633-40. doi: 10.1002/rcm.5163.